Tom Powles, Professor at the University of London, shared a post on X:
“Little data is available for BCG-unresponsive papillary only NMIBC. Here 52 patients received TAR200 (slow release GEM). 6 month DFS =85% (median follow up 12 mnths). Only 6% needed cystectomy. Well tolerated. Modest numbers/ follow up. More supportive TAR200 NMIBC data.”
More posts featuring Tom Powles
